InfuSystem Holdings, Inc (INFU) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, InfuSystem reported revenue of $143.4M, up 6.4% from $134.9M the year before. Net income was $6.6M (a 4.6% net margin), or $0.31 per diluted share. Gross margin was 56.0% and operating margin was 8.3%. Operating activities generated $24.4M of cash, leaving $23.8M of free cash flow. At fiscal year end, InfuSystem held $100.6M in total assets against $43.2M in total liabilities, including $3.2M of cash and equivalents.
Open the full interactive InfuSystem financials → Quarterly statements, key ratios, valuation history and price charts.
InfuSystem Key Stats
| Share Price | $13.49 |
|---|---|
| Market Cap | $282.2M |
| P/E Ratio | 43.5 |
| Revenue YoY Growth | +6.4% |
| 52-Week Range | $7.42 – $13.60 |
| Shares Outstanding | 20.1 million (basic, 2026 Q2) |
InfuSystem Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $97.4M | $102.4M | $109.9M | $125.8M | $134.9M | $143.4M |
| Cost of Goods Sold | $38.6M | $42.2M | $47.3M | $62.7M | $64.5M | $63.1M |
| Gross Profit | $58.8M | $60.2M | $62.6M | $63.1M | $70.4M | $80.3M |
| Operating Income | $8.8M | $2.8M | $1.7M | $4.1M | $6.9M | $11.9M |
| Pre-Tax Income | $7.5M | $1.3M | $130,000 | $1.9M | $5.1M | $10.6M |
| Income Tax | -$9.8M | -$163,000 | $112,000 | $979,000 | $2.7M | $4.0M |
| Net Income | $17.3M | $1.4M | $18,000 | $872,000 | $2.3M | $6.6M |
| Diluted EPS | $0.80 | $0.06 | — | $0.04 | $0.11 | $0.31 |
InfuSystem Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $36.5M | $36.2M | $33.7M | $36.9M |
| Net Income | $2.3M | $2.0M | $1.0M | $3.2M |
| Diluted EPS | $0.11 | $0.10 | $0.05 | $0.15 |
InfuSystem Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.6M | $186,000 | $165,000 | $231,000 | $527,000 | $3.2M |
| Current Assets | $29.8M | $22.1M | $24.8M | $30.6M | $32.2M | $36.3M |
| Total Assets | $97.0M | $97.6M | $99.4M | $102.9M | $103.6M | $100.6M |
| Current Liabilities | $23.0M | $12.9M | $14.5M | $15.7M | $17.7M | $20.2M |
| Total Long-Term Debt | $38.8M | $33.1M | $33.2M | $29.1M | $23.9M | $19.6M |
| Total Liabilities | $56.2M | $49.3M | $51.4M | $50.6M | $46.1M | $43.2M |
| Shareholders' Equity | $40.8M | $48.3M | $48.0M | $52.3M | $57.5M | $57.3M |
InfuSystem Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $20.3M | $18.3M | $17.5M | $11.2M | $20.5M | $24.4M |
| Cash From Investing | -$12.2M | -$21.3M | -$11.5M | -$6.7M | -$13.2M | -$6.8M |
| Cash From Financing | -$1.1M | -$6.5M | -$6.1M | -$4.4M | -$6.9M | -$15.0M |
| Free Cash Flow | $19.2M | $17.3M | $16.5M | $10.2M | $19.4M | $23.8M |
Figures from InfuSystem's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full InfuSystem financials page for every line item.
InfuSystem Company Profile
| Ticker | INFU |
|---|---|
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Rochester Hills, Michigan |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer, smaller reporting company |
| SEC CIK | 0001337013 |
Frequently Asked Questions
What was InfuSystem's revenue in fiscal 2025?
InfuSystem (INFU) reported revenue of $143.4M for fiscal 2025.
What is InfuSystem's annual revenue history?
InfuSystem's annual revenue by fiscal year: 2020: $97.4M; 2021: $102.4M; 2022: $109.9M; 2023: $125.8M; 2024: $134.9M; 2025: $143.4M.
What was InfuSystem's net income in fiscal 2025?
InfuSystem reported net income of $6.6M for fiscal 2025.
What was InfuSystem's earnings per share (EPS) in fiscal 2025?
InfuSystem's diluted EPS was $0.31 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did InfuSystem generate in fiscal 2025?
InfuSystem generated $23.8M of free cash flow in fiscal 2025.
What was InfuSystem's revenue last quarter?
In its most recent reported quarter (2026 Q2), InfuSystem reported revenue of $36.9M.
How much debt does InfuSystem have?
InfuSystem reported $19.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of InfuSystem are outstanding?
InfuSystem reported a weighted average of 20.1 million basic shares outstanding in 2026 Q2.
What is InfuSystem's market cap?
Based on its latest closing price, InfuSystem (INFU) has a market capitalization of about $282.2M.
When does InfuSystem's fiscal year end?
InfuSystem's fiscal year end, as registered with the SEC, is December 31.
Where is InfuSystem headquartered?
InfuSystem lists its business address in Rochester Hills, Michigan in its SEC filings.
InfuSystem Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →